Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

174 results
Display

Communication at the End of Life

Onishi H

End-of-life patients experience physical, mental, social, and existential distress. While medical personnel provide medication and care to alleviate patients’ distress, listening to and interacting with patients remains essential for understanding...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Medication Algorithm Project for Depressive Disorder 2021 (II): The Subtypes of Depression

Park YM, Seo JS, Woo YS, Bahk WM, Kim W, Jeong JH, Shim SH, Lee JG, Jang SH, Wang SM, Jung MH, Sung HM, Choo LH, Yoon BH, Lee SY, Jon DI, Min KJ

Objectives The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD) was developed in 2002 and revised in 2006, 2012, 2017. In 2021, the fifth edition was published. This edition reflected new...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Medication Algorithm Project for Depressive Disorder 2021 (I): Treatment Strategies for Major Depressive Episode

Woo YS, Bahk WM, Seo JS, Park YM, Kim W, Jeong JH, Shim SH, Lee JG, Jang SH, Wang SM, Jung MH, Sung HM, Choo IH, Yoon BH, Lee SY, Jon DI, Min KJ

Objectives The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD) is a consensus-based medication guideline. To reflect advances in pharmacotherapy for depressive disorders, we have undertaken a fourth revision of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Does the Loudness Dependence of Auditory Evoked Potential Predict Response to Selective Serotonin Reuptake Inhibitors?: A Meta-analysis

Yoon S, Kim Y, Lee SH

Objective: Loudness of dependence of the auditory evoked potential (LDAEP) is an electroencephalogram-based measure that represents amplitude changes of auditory evoked potentials in primary auditory cortex. Several narrative reviews argued...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Additional Reduction of Residual Symptoms with Aripiprazole Augmentation in the Patients with Partially Remitted Major Depressive Disorder

Shin C, Pae CU, Kwak KP, Jeon SW, Jeong HG, Kim JW, Lee YJ, Patkar AA, Han C

Objective: Many patients with major depressive disorder (MDD) suffer from residual symptoms without achieving remission. However, pharmacologic options for residual symptoms of MDD have been limited. This study aimed to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Burden of Agoraphobia in Worsening Quality of Life in a Community Survey in Italy

Preti A, Piras M, Cossu G, Pintus E, Pintus M, Kalcev G, Cabras F, Moro MF, Romano F, Balestrieri M, Caraci F, Dell’Osso L, Sciascio GD, Drago F, Hardoy MC, Roncone R, Faravelli C, Musu M, Finco G, Nardi AE, Carta MG

Objective Current nosology redefined agoraphobia as an autonomous diagnosis distinct from panic disorder. We investigated the lifetime prevalence of agoraphobia, its association with other mental disorders, and its impact on...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Is Job Insecurity Worse for Mental Health Than Having a Part-time Job in Canada?

Kim IH, Choi CC, Urbanoski K, Park J, Kim J

Objectives: A growing number of people depend on flexible employment, characterized by outsider employment status and perceived job insecurity. This study investigated whether there was a synergistic effect of employment...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Rapid Symptom Improvement in Major Depressive Disorder Using Accelerated Repetitive Transcranial Magnetic Stimulation

Kim SJ, Son SJ, Jang M, Kim BH, Hong SJ, Seo L, Choi SW, Seok JH, Noh JS

Objective: Repetitive transcranial magnetic stimulation (rTMS) has contributed to increase in the remission rate for patients with major depressive disorder (MDD). However, current rTMS treatment is practically inconvenient because it...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Biomarkers of Major Depressive Disorder: Knowing is Half the Battle

Malik S, Singh R, Arora G, Dangol A, Goyal S

Major depressive disorder (MDD) is a heterogeneous disease which is why there are currently no specific methods to accurately test the severity, endophenotype or therapy response. This lack of progress...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Mismatch Negativity According to Suicidal Ideation in Patients With Major Depressive Disorder

Lee M, Lee YJ, Hwang J, Woo Si, Kim MJ, Kang B, Kim Y, Hahn SW

Objective : Mismatch negativity (MMN) is known to reflect several abnormalities of cognitive function-ing. This study is aimed to investigate the differences in MMN among major depressive disorder (MDD) patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Alterations in the Occipital Cortex of Drug-Naïve Adults With Major Depressive Disorder: A Surface-Based Analysis of Surface Area and Cortical Thickness

Lee JS, Kang W, Kang Y, Kim A, Han KM, Tae WS, Ham BJ

Objective Advances in surface-based morphometric methods have allowed researchers to separate cortical volume into cortical thickness (CTh) and surface area (SA). Although CTh alterations in major depressive disorder (MDD) have...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
How Inflammation Affects the Brain in Depression: A Review of Functional and Structural MRI Studies

Han KM, Ham BJ

This narrative review discusses how peripheral and central inflammation processes affect brain function and structure in depression, and reports on recent peripheral inflammatory marker-based functional and structural magnetic resonance imaging...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Trends in the Prevalence of Major Depressive Disorder by Sociodemographic Factors in Korea: Results from Nationwide General Population Surveys in 2001, 2006, and 2011

Lee J, Kim H, Hong JP, Cho SJ, Lee JY, Jeon HJ, Kim BS, Chang SM

Background: This study investigated trends in the prevalence of major depressive disorder (MDD) by sociodemographic factors in South Korea. Methods: National samples of the general population aged 18 years or older...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Shape and Volumetric Differences in the Corpus Callosum between Patients with Major Depressive Disorder and Healthy Controls

Lee S, Pyun SB, Choi KW, Tae WS

Objective This study aimed to investigate the morphometric differences in the corpus callosum between patients with major depressive disorder (MDD) and healthy controls and analyze their relationship to gray matter...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Reduced Temporal Activation During a Verbal Fluency Task is Associated with Poor Motor Speed in Patients with Major Depressive Disorder

Kiriyama T, Tanemura R, Nakamura Y, Takemoto C, Hashimoto M, Utsumi H

Objective Substantial research has revealed cognitive function impairments in patients with major depressive disorder (MDD). However, the relationship between MDD cognitive function impairment and brain activity is yet to be...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of Buspirone Augmentation of Escitalopram in Patients with Major Depressive Disorder with and without Atypical Features: A Randomized, 8 Week, Multicenter, Open-Label Clinical Trial

Shin C, Ko YH, Shim SH, Kim JS, Na KS, Hahn SW, Lee SH

Objective This study investigated the treatment response and cognitive enhancement effects of buspirone augmentation of escitalopram in patients with major depressive disorder (MDD), according to atypical feature subtypes of MDD. Methods...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Serum Uric Acid in Major Depressive Disorder and Bipolar Disorder: a Retrospective Chart Review Study

Kim S, Rhee SJ, Song Y, Ahn YM

Background: Uric acid (UA) has been suggested as a possible biomarker of bipolar disorder (BD) in recent studies. We aimed to provide a clearer comparison of UA levels between BD...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Brain Imaging Study on the Pathogenesis of Depression & Therapeutic Effect of Selective Serotonin Reuptake Inhibitors

Meng Q, Zhang A, Cao X, Sun N, Li X, Zhang Y, Wang Y

Objective Predefining the most effective treatment for patients with depressive disorders remains a problem. We will examine the differential brain regions of gray matter (GM) in major depressive disorder (MDD)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
ZNF804A Gene Variants Have a Cross-diagnostic Influence on Psychosis and Treatment Improvement in Mood Disorders

Calabrò M, Mandelli L, Crisafulli C, Nicola MD, Colombo R, Janiri L, Lee SJ, Jun TY, Wang SM, Masand PS, Patkar AA, Han C, Pae CU, Serretti A

Objective: Genetic variations in the gene encoding zinc finger protein 804A gene (ZNF804A) have been associated with major depression and bipolar disorder. In this work we focused on the potential...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Shape Deformation in the Brainstem of Medication-Naïve Female Patients with Major Depressive Disorder

Choi KW, Kwon S, Pyun SB, Tae WS

Objective Although neuroimaging studies have shown volumetric reductions, such as the anterior cingulate, prefrontal cortices, and hippocampus in patients with major depressive disorder (MDD), few studies have investigated the volume...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr